Could ‘controversial’ pharma court ruling provide ‘wiggle room’ for off-label dietary supplement marketing?
A recent ruling by the US appeals court protecting free-speech relating to off-label use of pharmaceuticals may have ‘far reaching effects’ for the nutritional supplement business, says a leading industry figure.